Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2631 of 5804
-
New speech therapy aims to help nonverbal kids with autism find their voice
Symptom relief Recruiting nowComorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally v…
Phase: NA • Sponsor: MGH Institute of Health Professions • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Registry screening aims to close gaps in heart failure care
Disease control Recruiting nowRationale. Although several pharmacological treatments, namely renin-angiotensin-system inhibitors, sacubitril/valsartan, beta-blockers, mineralocorticoid receptor antagonists and sodium-glucose cotransporter-2 inhibitors, improve mortality/morbidity in heart failure with reduced…
Phase: NA • Sponsor: Region Stockholm • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC
-
Massage may soothe anxiety by calming brain circuits
Symptom relief Recruiting nowThis clinical trial will compare the effects of Swedish massage or light touch therapy on brain activity and symptoms of anxiety. This is a randomized research study and subjects will be randomized into one of two study touch intervention groups, and will have an equal chance of…
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 26, 2026 14:59 UTC
-
New program aims to help hispanic teens kick the vape habit
Disease control OngoingInvestigators will create and implement an e-cigarette intervention for Hispanic/Latino (H/L) high school youth. Focus groups with the target population (i.e., H/L high school students) and meetings with a community advisory board (CAB) will inform this intervention. The interven…
Phase: NA • Sponsor: Florida International University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New study: could physical therapy boost hip injection results?
Symptom relief Recruiting nowHip pathologies that cause pain and functional limitations are common in the general population. These can include femoroacetabular impingement (FAI), labral tears and mild osteoarthritis (OA) among others. While more severe and symptomatic cases may require surgical intervention…
Phase: NA • Sponsor: ArthroBiologix Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Less invasive parotid tumor surgery may reduce nerve damage risk
Disease control CompletedBenign parotid gland tumors, such as pleomorphic adenoma and Warthin tumors, constitute the majority of salivary gland neoplasms. Surgical excision remains the primary treatment, traditionally achieved through superficial parotidectomy (SP). However, SP may lead to complications …
Phase: NA • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can fixing sleep heal blood vessels after childhood trauma?
Knowledge-focused Recruiting nowThe overall purpose of this study is to understand the role of disrupted sleep in the association of exposure to early life adversity (adverse childhood experiences (ACEs)) with vascular endothelial (dys)function. In Aim 1 (The Iowa ACEs and Sleep Cohort Study), the investigator…
Phase: NA • Sponsor: Nathaniel Jenkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Buriti fruit boosts weight and strength in the oldest old
Disease control CompletedThe population aged over 90 is growing worldwide, and the search for strategies to promote a better quality of life for the older persons is a challenge for science. Advancing age is associated with several physiological changes leading to different diseases, among which malnutri…
Phase: NA • Sponsor: Federal University of Minas Gerais • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Tai chi tailored for Parkinson's shows promise in small trial
Symptom relief OngoingThis pilot study evaluates whether a structured, Parkinson's disease-specific Tai Chi programme ("Enhanced Tai Chi") can improve motor and non-motor symptoms in people with Parkinson's disease (PD). PD is a progressive neurological condition associated with motor impairments suc…
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New PET tracer could spot Parkinson's protein in living brains
Knowledge-focused Recruiting nowThe overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls. The purpose…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Preterm birth linked to exercise resistance: mitochondrial clues emerge
Knowledge-focused Recruiting nowYoung adults born very preterm (32 weeks gestation or earlier) do not respond well to aerobic exercise training, meeting the recommendations set by the Physical Activity Guidelines for Americans, where they do not increase their fitness level (or cardiorespiratory fitness). Thus,…
Phase: NA • Sponsor: Texas Tech University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New cancer drug YL211 enters first human tests
Disease control Recruiting nowThis is a multicenter, open-label, Phase 1 study. The study will enroll subjects with advanced solid tumors. It consists of six parts. Objectives for Dose-Escalation Parts (Part 1 and Part 4) To evaluate the safety and tolerability of YL211 as monotherapy in patients with selecte…
Phase: PHASE1 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Cancer combo trial halted early: what happened?
Disease control TerminatedThis research was done to evaluate the safety and effectiveness of a drug currently known as Azenosertib (ZN-C3) in combination with the drugs carboplatin and pembrolizumab in metastatic triple-negative breast cancer. The names of the study drugs involved in this study are: * A…
Phase: PHASE1 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy aims to soothe pain and stiffness after head and neck cancer surgery
Symptom relief OngoingThe goal of this clinical trial is to determine whether far-infrared therapy and transcutaneous electrical nerve stimulation (TENS) can improve postoperative side effects in patients with head and neck cancer. The main questions this study aims to answer are: Can far-infrared th…
Phase: NA • Sponsor: Buddhist Tzu Chi General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can group CBT help teens overcome social anxiety?
Symptom relief CompletedThis randomized controlled trial aims to evaluate the efficacy of a 2-month group Cognitive Behavioral Therapy (CBT) intervention compared to a structured psychoeducational treatment as usual (TAU) in adolescents diagnosed with Social Anxiety Disorder. Participants aged 12 to 17…
Phase: NA • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a tiny device free people with type 1 diabetes from daily shots?
Disease control OngoingThe purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes.
Phase: PHASE1 • Sponsor: Encellin • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
ECMO blood thinner showdown: which drug wins?
Disease control Recruiting nowThe goal of this open label randomised clinical trial is to compare Bivalirudin versus Heparin for anticoagulation in patients requiring extracorporeal membrane oxygenation support. The main question it aims to answer are include the ability to maintain anticoagulation within de…
Phase: PHASE2 • Sponsor: Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a smartwatch and nutrition coaching ease cirrhosis symptoms?
Symptom relief Recruiting nowRemote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention c…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can your own blood ease knee pain? new study tests PRP therapy
Symptom relief OngoingOsteoarthritis (OA) is a disease that affects the joints of the body, causing pain, stiffness, and reduced mobility. To treat knee OA, a therapy called platelet-rich plasma (PRP) is used, which involves making a concentrated substance from the patient's own blood and injecting it…
Phase: PHASE2 • Sponsor: Universidad Nacional de Entre Rios • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Uganda program aims to stop heart disease in its tracks
Disease control Recruiting nowThe goal of this prospective study is to evaluate the feasibility, sustainability, and public health impact of a district-based program for secondary prevention of Rheumatic Heart Disease (RHD) in Uganda.
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC